Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CLSA Premium Ltd. ( (HK:6877) ) has issued an announcement.
Top Eminent Healthcare Group has updated the terms of reference for its Remuneration Committee to align with the latest Corporate Governance Code under Hong Kong listing rules. The committee must comprise at least three directors with a majority of independent non-executive members, be chaired by an independent non-executive director, and be supported by a company secretary or similarly qualified appointee.
The revised framework sets minimum meeting frequency, quorum requirements and notice periods, and formalizes procedures for written resolutions and participation via teleconference. By tightening governance over director and senior management pay oversight, the company aims to reinforce regulatory compliance, transparency and board effectiveness, with potential implications for remuneration structures and stakeholder confidence.
The most recent analyst rating on (HK:6877) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on CLSA Premium Ltd. stock, see the HK:6877 Stock Forecast page.
More about CLSA Premium Ltd.
Top Eminent Healthcare Group Limited is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange under stock code 6877. The group operates in the healthcare sector, though the document focuses on its corporate governance framework rather than specific products, services or market segments.
Average Trading Volume: 943,061
Technical Sentiment Signal: Sell
Current Market Cap: HK$335.5M
See more data about 6877 stock on TipRanks’ Stock Analysis page.